Merck & Co Earnings & Forecasts

Merck & Co (MRK) earnings history, EPS estimates, revenue forecasts and company guidance.

Merck & Co Guidance

Merck & Co (MRK)은 지난 8월 4, 2026에 fiscal year 2026의 실적 전망을 발표했습니다. 회사는 주당순이익을 $2.66 - $2.76 범위로 전망했으며, 이는 시장 컨센서스 EPS 추정치인 $3.42보다 높은 수치입니다. Merck & Co는 또한 해당 기간의 매출을 $66.3B - $67.3B 범위로 전망했습니다.

이전 가이던스와 비교하여 Merck & Co는 주당순이익(EPS) 전망치를 이전 범위인 하향 조정됨에서 $5.04 - $5.16로 상향 조정했습니다. 매출 측면에서는 회사가 매출 전망치를 이전 범위인 유지됨에서 $65.8B - $67B로 상향 조정했습니다.

Merck & Co은 16과 10월 27, 2022 사이에 8월 4, 2026개의 지침 업데이트를 발표했습니다. During this period, the company raised its outlook 3 times and lowered it 6 times, providing investors with insight into management's evolving expectations.

Analyst Estimates — Forward PeriodsSource: Wall Street consensus

Metric	Q3 '26E	Q4 '26E	Q1 '27E	Q2 '27E
Earnings Per Share (Non-GAAP)
Consensus	$2.10	$1.95	$2.45	$2.40
Revenue
Consensus	$17.30B	$16.83B	—	—

More with Benzinga EdgeGet Access

Earnings & Guidance News

AMD Hits $1 Trillion, Muse Spooks Subscription Stocks: This Week on Wall Street

AMD crossed $1 trillion and Meta's Muse rattled subscription stocks. Meanwhile, Treasury yields hit 2007 highs.

Piero Cingari

Stock Market Today: Dow Jones, S&P 500, Nasdaq 100 Futures Fall as Trump Launches ‘Operation Economic Fury’ on Iran— BULL, WMT, MRK Stock in Focus (UPDATED)

Editor’s note: The ETFs data was updated and economic data was added U.S. stock futures were lower on Thursday, as the Dow Jones, S&P 500 and Nasdaq 100 indices fell, following Wednesday’s higher

Rishabh Mishra

Moderna Doubles, Gold Rallies To $4,500 As Dollar Sinks: Stock Market Today

Treasury's expanded long-bond buybacks knocked yields off 20-month highs and sank the dollar, as gold soars.

Piero Cingari

Why Merck Just Slashed Its Profit Outlook By Nearly 50%

Merck cuts FY2026 adjusted EPS outlook nearly in half to $2.66-$2.76, citing $2.43/share in charges from its Terns acquisition.

Vandana Singh

PRO
Merck & Co Lowers FY2026 Adj EPS Guidance from $5.04-$5.16 to $2.66-$2.76 vs $2.76 Est; Raises FY2026 Sales Guidance from $65.800B-$67.000B to $66.300B-$67.300B vs $66.802B Est

Merck & Co (NYSE:MRK) lowers FY2026 Adj EPS guidance from $5.04-$5.16 to $2.66-$2.76 vs $2.76 analyst estimate. Raises FY2026 sales outlook from $65.800 billion-$67.000 billion to $66.300 billion-$67.300 billion vs

Benzinga Newsdesk

PRO
Merck & Co Q2 Adj. EPS $(0.13) Beats $(0.27) Estimate, Sales $16.607B Beat $16.356B Estimate

Merck & Co (NYSE:MRK) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.27) by 51.85 percent. This is a 106.1 percent decrease over earnings of $2.13 per share from the

Benzinga Newsdesk

Merck & Co Inc

뉴스

파트너 / 기고자

벤징가 글로벌